Vaxart, Inc. (VXRT) stock
VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026Market cap $115.61MP/E 4.0Yield –
Vaxart gross margin
Gross margin is gross profit as a percentage of revenue.
Vaxart's gross margin for the twelve months ending Jun 30, 2016 was -271.0%. For fiscal 2015 it was 85.4%, against 25.6% the year before. The highest annual figure on record is 85.4% in fiscal 2015.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | 85.4% | +59.7 |
| FY2014 | Jun 30, 2014 | 25.6% | −15.8 |
| FY2013 | Jun 30, 2013 | 41.4% | −10.1 |
| FY2012 | Jun 30, 2012 | 51.5% | −29.6 |
| FY2009 | Dec 26, 2009 | 81.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -1133.3% | −645.5 |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -98.1% | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -382.4% | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -394.1% | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -487.8% | – |
See a number that looks wrong?